-
Recent Posts
Meta
-
Monthly Archives: March 2011
Scoopasia | Press Releases
This involved the reconstruction of the entire eye surface and replacement of the diseased cornea with an artificial cornea transplant. Boston KPro surgery is one of the most specialised and complicated surgeries for the eye, … Continue reading
Posted in cornea
Tagged cornea, diseased, entire, eye-surface, involved, reconstruction, the-diseased, the-entire, the-eye, the-most
Leave a comment
Business Diary: Green alternative to Royal Bank?
Residents of Edinburgh West will be pleased to hear their Liberal Democrat MP, Mike Crockart, is doing his best to bring new jobs to the constituency. Crockart was leading a delegation at the House of Commons yesterday calling for the headquarters of the new Green Investment Bank to be sited in the area he represents Continue reading
Posted in eye disease, eye treatmeant
Tagged area, bring-new, commons, constituency, crockart, edinburgh, edinburgh-west, green, headquarters, house, liberal, little-greedy, royal, royal-bank, the-area
Leave a comment
Frizz-free hair: one woman’s quest for the taming of the ‘do
Keratin treatments promise great results, if you can get over the fear of formaldehyde and the shock of the price. Continue reading
Posted in eye disease, eye treatmeant
Tagged fear, get-over, great-results, over-the-fear, price, shock, the-fear, treatments-promise
Leave a comment
UV exposure in light-adjustable IOL process causes no harm to …
In particular, the study was designed to evaluate the effect of the UV-induced power adjustment and lock-in procedures on the inner layer of cells in the cornea (endothelium), which controls the fluid balance and clarity of the front … Continue reading
Posted in cornea, eye alternative treatment
Tagged controls-the-fluid, cornea, effect, evaluate-the-effect, fluid, study, the-fluid, the-front, the-inner, the-study
Leave a comment
Head-to-head eye drug results tipped for early May
* Lucentis vs Avastin study may feature at May 1-5 congress * Lucentis at risk if far cheaper Avastin proves as good * Lucentis brings in $1.5 bln/yr for both Roche and Novartis LONDON, March 30 (Reuters) … Continue reading
Posted in eye treatmeant
Tagged avastin, far-cheaper, feature-at-may, lucentis, lucentis-at-risk, novartis, proves-as-good, roche, study-may
Leave a comment